ストックスクリーナーアプリを入手
18.01
2.80%
0.51
前日終値:
$17.50
開ける：
$18.12
24時間の取引高:
370.85K
Relative Volume:
0.36
時価総額：
$605.03M
収益：
-
当期純損益:
$-47.20M
株価収益率:
-11.51
EPS:
-1.5653
ネットキャッシュフロー:
$-43.65M
1週間 パフォーマンス:
-10.50%
1か月 パフォーマンス:
+19.22%
6か月 パフォーマンス:
+162.24%
1年 パフォーマンス:
-25.23%
1日の値動き範囲:
$17.70
$18.22
1週間の範囲:
$16.89
$18.45
52週間の値動き範囲:
$4.8069
$27.50
Mbx Biosciences Inc Stock (MBX) Company Profile
MBX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MBX
Mbx Biosciences Inc
|
18.01 | 782.52M | 0 | -47.20M | -43.65M | -1.5653 |
|
VRTX
Vertex Pharmaceuticals Inc
|
403.21 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.84 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
459.38 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
768.65 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
343.93 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-15 | 再開されました | Jefferies | Buy |
| 2025-08-05 | 開始されました | Mizuho | Outperform |
| 2025-07-16 | 開始されました | Oppenheimer | Outperform |
| 2025-04-10 | 開始されました | Citizens JMP | Mkt Outperform |
| 2024-10-08 | 開始されました | Guggenheim | Buy |
| 2024-10-08 | 開始されました | JP Morgan | Overweight |
| 2024-10-08 | 開始されました | Jefferies | Buy |
| 2024-10-08 | 開始されました | Stifel | Buy |
すべてを表示
Mbx Biosciences Inc (MBX) 最新ニュース
Is it too late to sell MBX Biosciences Inc.Dollar Strength & Safe Swing Trade Setup Alerts - newser.com
How MBX Biosciences Inc. stock reacts to bond yieldsWeekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com
Using AI based signals to follow MBX Biosciences Inc.Portfolio Growth Summary & Accurate Entry and Exit Point Alerts - newser.com
MBX Biosciences Inc. stock momentum explainedIPO Watch & Risk Managed Investment Strategies - newser.com
Massive Stock Purchase by MBX Biosciences Director! - TipRanks
Goldman Sachs Group Inc. Has $112,000 Stock Holdings in MBX Biosciences, Inc. $MBX - MarketBeat
Analyzing MBX Biosciences Inc. with multi timeframe chartsWeekly Stock Analysis & Free Fast Gain Swing Trade Alerts - newser.com
MBX Biosciences to Participate in the Stifel 2025 Virtual Cardiometabolic Forum - GlobeNewswire
Precision Peptide Innovator MBX Biosciences Featured at Stifel 2025 Cardiometabolic Forum - Stock Titan
Is MBX Biosciences Inc. stock a defensive play in 2025Market Activity Report & Stepwise Entry and Exit Trade Signals - newser.com
Will MBX Biosciences Inc. bounce back from current supportMarket Performance Report & AI Powered Market Entry Strategies - newser.com
MBX Biosciences stock down on pricing upsized public offering at $18.00 per share - MSN
Is MBX Biosciences Inc a good long term investmentTrading Volume Trends & Learn the Basics of Investing in 5 Days - earlytimes.in
MBX Biosciences Inc Stock Analysis and ForecastProtective Put Strategies & Unlock Long-Term Capital Growth Ideas - earlytimes.in
MBX, uniQure among biotechs raising nine-figure sums: Public Equity Report - BioCentury
MBX Biosciences Announces Public Offering Agreement - TipRanks
How MBX Biosciences Inc. stock compares to market leaders2025 AllTime Highs & Verified Short-Term Plans - newser.com
MBX Biosciences Reports Promising Phase 2 Trial Results - MSN
MBX Biosciences (NASDAQ:MBX) Shares Gap DownTime to Sell? - MarketBeat
MBX Biosciences Shares Drop Following Upsized Public Offering Pricing - MSN
MBX Biosciences stock falls after pricing upsized public offering By Investing.com - Investing.com Nigeria
MBX Biosciences stock falls after pricing upsized public offering - Investing.com
Stitch Fix Posts Q4 Results, Joins Transocean, MBX Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
MBX Biosciences slips after $200 mln stock offering - TradingView
MBX Biosciences Prices Upsized $200 Million Common Stock Offering - MarketScreener
MBX Biosciences Announces Pricing of Upsized Public Offering - The Manila Times
Transcript : MBX Biosciences, Inc.Special Call - MarketScreener
$199.9 Million Raise: Biotech MBX Biosciences Prices Upsized Public Offering of 11.1M Shares at $18 - Stock Titan
MBX Biosciences announces pricing of upsized public offering of 11,108,055 shares at $18.00 per share - MarketScreener
MBX Biosciences: Mizuho Raises Price Target to $56 Amidst Outper - GuruFocus
Mizuho Increases MBX Biosciences (NYSE:MBX) Price Target to $56.00 - MarketBeat
Wall Street Analysts Think MBX Biosciences, Inc. (MBX) Could Surge 88.55%: Read This Before Placing a Bet - MSN
MBX Biosciences stock price target raised to $56 from $38 at Mizuho - Investing.com
MBX Biosciences price target raised to $56 from $38 at Mizuho - TipRanks
MBX Biosciences stock price target raised to $84 from $44 at Guggenheim - Investing.com Canada
MBX Biosciences (NYSE:MBX) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
MBX Biosciences (NASDAQ:MBX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Mizuho Securities Maintains MBX Biosciences(MBX.US) With Buy Rating, Announces Target Price $56 - 富途牛牛
MBX Biosciences eases after stock offering announced - TradingView
Citizens JMP Maintains MBX Biosciences(MBX.US) With Buy Rating, Raises Target Price to $61 - 富途牛牛
MBX Biosciences (MBX) Is Up 84.0% After Positive Phase 2 Results for CanvuparatideHas The Bull Case Changed? - Yahoo Finance
MBX Biosciences reports positive Phase 2 results for hypoparathyroidism drug - Investing.com Nigeria
AutoZone, Micron Technology And 3 Stocks To Watch Heading Into Tuesday - Benzinga
Developing predictive dashboards with MBX Biosciences Inc. dataShort Setup & Technical Analysis for Trade Confirmation - newser.com
MBX Biosciences files for public offering of 10 million shares By Investing.com - Investing.com Nigeria
MBX Biosciences files for public offering of 10 million shares - Investing.com India
MBX Biosciences Stock Rockets on Clinical Trial Update - TipRanks
Mbx Biosciences Inc (MBX) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
大文字化:
|
ボリューム (24 時間):